+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Advanced Heart Failure Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Advanced Heart Failure Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Acute Pain Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Acute Pain Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Acute Gout Flare Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Acute Gout Flare Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Wilson Disease Pipeline Analysis Report 2025 - Product Thumbnail Image

Wilson Disease Pipeline Analysis Report 2025

  • Report
  • June 2025
  • 200 Pages
  • Global
From
From
Diclofenac Market Report and Forecast 2025-2034 - Product Thumbnail Image

Diclofenac Market Report and Forecast 2025-2034

  • Report
  • June 2025
  • 400 Pages
  • Global
From
Amblyopia Treatment Market Report and Forecast 2025-2034 - Product Thumbnail Image

Amblyopia Treatment Market Report and Forecast 2025-2034

  • Report
  • June 2025
  • 400 Pages
  • Global
From
Tay Sachs Disease Pipeline Analysis Report 2025 - Product Thumbnail Image

Tay Sachs Disease Pipeline Analysis Report 2025

  • Report
  • June 2025
  • 200 Pages
  • Global
From
IgA Nephropathy Pipeline Analysis 2025 - Product Thumbnail Image

IgA Nephropathy Pipeline Analysis 2025

  • Report
  • June 2025
  • 200 Pages
  • Global
From
Hypertrophic Cardiomyopathy Pipeline Analysis Report 2025 - Product Thumbnail Image

Hypertrophic Cardiomyopathy Pipeline Analysis Report 2025

  • Report
  • June 2025
  • 200 Pages
  • Global
From
From
Food Allergy Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Food Allergy Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Febrile Neutropenia Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Febrile Neutropenia Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Eosinophilic Asthma Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Eosinophilic Asthma Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
End Stage Renal Disease Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

End Stage Renal Disease Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Encephalopathy Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Encephalopathy Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Eczema Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Eczema Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Down Syndrome Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Down Syndrome Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Diarrhea Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Diarrhea Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Diabetic Peripheral Neuropathy Pipeline Analysis Report 2025 - Product Thumbnail Image

Diabetic Peripheral Neuropathy Pipeline Analysis Report 2025

  • Report
  • June 2025
  • 200 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more